{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05053867",
            "orgStudyIdInfo": {
                "id": "2019-0991"
            },
            "secondaryIdInfos": [
                {
                    "id": "NCI-2021-09676",
                    "type": "OTHER",
                    "domain": "NCI-CTRP Clinical Trials Gov Registry"
                }
            ],
            "organization": {
                "fullName": "M.D. Anderson Cancer Center",
                "class": "OTHER"
            },
            "briefTitle": "A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients",
            "officialTitle": "A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients",
            "therapeuticArea": [
                "Respiratory",
                "Oncology and Hematology"
            ],
            "study": "a-randomized-controlled-trial-of-inhaled-tranexamic-acid-for-the-treatment-of-pulmonary-hemorrhage-in-cancer-patients"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "startDateStruct": {
                "date": "2022-10-14",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-07-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-07-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-09-02",
            "studyFirstSubmitQcDate": "2021-09-20",
            "studyFirstPostDateStruct": {
                "date": "2021-09-23",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-19",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-24",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "M.D. Anderson Cancer Center",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a drug study that will examine if inhaled tranexamic acid can improve mortality in patients with cancer-related pulmonary hemorrhage and respiratory failure as compared to usual care.",
            "detailedDescription": "Primary Objective: To assess the benefit of using nebulized tranexamic acid versus the standard of care on 30 day mortality.\n\nSecondary Objectives: To assess the following outcomes when using nebulized tranexamic acid versus the standard of care:\n\n1. 100 day, ICU and hospital mortality rate\n2. Ventilator days at day 30\n3. ICU and Hospital Length of Stay\n4. PaO2:FIO2 ratio (or SpO2:FIO2 ratio) changes over the first 14 days\n5. Time to resolution of pulmonary hemorrhage\n6. Rate of recurrence of pulmonary hemorrhage\n7. Rate of invasive procedures required to control pulmonary hemorrhage"
        },
        "conditionsModule": {
            "conditions": [
                "Pulmonary Hemorrhage",
                "Cancer"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 60,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Group A: Inhaled tranexamic acid",
                    "type": "EXPERIMENTAL",
                    "description": "will receive 500 mg/5ml nebulized tranexamic acid every 8 hours for at least 3 days, and up to 5 days",
                    "interventionNames": [
                        "Drug: tranexamic acid"
                    ]
                },
                {
                    "label": "Group B: Usual Care",
                    "type": "OTHER",
                    "description": "usual care",
                    "interventionNames": [
                        "Other: Usual Care"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "tranexamic acid",
                    "description": "Inhaled",
                    "armGroupLabels": [
                        "Group A: Inhaled tranexamic acid"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Usual Care",
                    "description": "Standard of Care",
                    "armGroupLabels": [
                        "Group B: Usual Care"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "28 day all-cause mortality rate",
                    "description": "Number of patients who are alive at 28 days following randomization. The difference between 28-day mortality rates between treatment arms will be computed along with a 95% confidence interval (CI) using the approximate standard error reported in Fleiss (1981). Logistic regression will be used to estimate the association between 28-day mortality and study covariates of interest.",
                    "timeFrame": "up to 28 days"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Age \\> 18 years old\n2. Have a diagnosed hematological malignancy\n3. Are actively receiving mechanical ventilation\n4. Have evidence of pulmonary hemorrhage as defined by either\n\n   1. Persistently bloody secretions upon endotracheal tube suctioning, or\n   2. Evidence of diffuse alveolar hemorrhage by bronchoscopic examination\n5. Signed informed consent by patient or if the subject lacks decision-making capacity, the subject's legally authorized representative\n\n2.3.2 Exclusion Criteria\n\nPatients excluded from participation in the study if any of the following criteria are met:\n\n1. Presence of a Do Not Resuscitate (DNR), no escalation of care or comfort care order at the time of screening\n2. Expected survival \\< 48 hours\n3. Evidence of nasal or oral spillage likely to be the cause of bloody secretions\n4. Patients requiring 100% FIO2\n5. Known hypersensitivity to tranexamic acid\n6. Treatment with inhaled tranexamic acid prior to screening\n7. Acquired defective color vision\n8. Subarachnoid hemorrhage\n9. Deep Venous or arterial thrombus diagnosed within the previous 3 months\n10. Seizure disorder on active anti-epileptic therapies\n11. Hypersensitivity to tranexamic acid or any of the ingredients\n12. Pregnant women will not be eligible and have a negative pregnancy test prior to entering study\n13. Patient receiving concurrent anti-fibrinolytic therapy\n14. Confirmed active COVID-19 infection",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Nisha Rathi, MD",
                    "role": "CONTACT",
                    "phone": "713-745-5787",
                    "email": "nrathi@mdanderson.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Nisha Rathi, MD",
                    "affiliation": "M.D. Anderson Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "M D Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Nisha Rathi, MD",
                            "role": "CONTACT",
                            "phone": "713-745-5787",
                            "email": "nrathi@mdanderson.org"
                        },
                        {
                            "name": "Nisha Rathi, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "M D Anderson Cancer Center",
                    "url": "http://www.mdanderson.org"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006470",
                    "term": "Hemorrhage"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M27137",
                    "name": "Respiratory Aspiration",
                    "relevance": "LOW"
                },
                {
                    "id": "M9556",
                    "name": "Hemorrhage",
                    "asFound": "Hemorrhage",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000014148",
                    "term": "Tranexamic Acid"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000933",
                    "term": "Antifibrinolytic Agents"
                },
                {
                    "id": "D000050299",
                    "term": "Fibrin Modulating Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000006490",
                    "term": "Hemostatics"
                },
                {
                    "id": "D000003029",
                    "term": "Coagulants"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16902",
                    "name": "Tranexamic Acid",
                    "asFound": "Non-Small Cell Lung Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4252",
                    "name": "Antifibrinolytic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M9576",
                    "name": "Hemostatics",
                    "relevance": "LOW"
                },
                {
                    "id": "M6259",
                    "name": "Coagulants",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Coag",
                    "name": "Coagulants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}